Biotechnology Companies Face New Regulatory and Commercial Challenges. When Should They Bring in Outside Counsel?

Biotechnology companies face important legal and commercial decisions as they develop new therapies, negotiate partnerships, and expand into international markets. We examine when outside counsel can help companies address U.S. regulatory requirements, pharmaceutical licensing, reimbursement, commercial agreements, and cross-border business arrangements.